The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Cohen Matthew Gregory | Director | Grant(A) | 12K | — | $0 |
| May 12, 2026 | Lu Hongbo | Director | Sell(S) | 3K | $76.88 | $228K |
| Apr 23, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 10K | $75.00 | $750K |
| Apr 22, 2026 | Apel Daniel Joseph | Chief Financial Officer | Sell(S) | 3K | $70.11 | $225K |
| Apr 22, 2026 | Apel Daniel Joseph | Chief Financial Officer | Sell(S) | 1K | $70.45 | $82K |
| Apr 22, 2026 | Apel Daniel Joseph | Chief Financial Officer | Sell(S) | 9K | $71.92 | $628K |
| Mar 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 10K | $64.19 | $642K |
| Jan 6, 2026 | O'Brien Patrick | COO | Gift(G) | 540 | — | $0 |
| Jan 6, 2026 | O'Brien Patrick | COO | Grant(A) | 75K | — | $0 |
| Jan 6, 2026 | O'Brien Patrick | COO | Gift(G) | 440 | — | $0 |
| Jan 6, 2026 | O'Brien Patrick | COO | Gift(G) | 540 | — | $0 |
| Jan 6, 2026 | O'Brien Patrick | COO | Gift(G) | 540 | — | $0 |
| Jan 6, 2026 | O'Brien Patrick | COO | Gift(G) | 440 | — | $0 |
| Jan 6, 2026 | Hamilton James C | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Jan 6, 2026 | Apel Daniel Joseph | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 46 | $68.00 | $3K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 4K | $61.20 | $267K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 6K | $62.23 | $384K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 13K | $62.96 | $847K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 12K | $63.84 | $756K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 3K | $64.44 | $174K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 900 | $66.01 | $59K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 313 | $68.00 | $21K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 600 | $61.12 | $37K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 900 | $62.25 | $56K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 6K | $62.91 | $369K |
| Jan 5, 2026 | O'Brien Patrick | COO | Sell(S) | 2K | $64.04 | $150K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 5K | $61.24 | $283K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 6K | $62.28 | $379K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 15K | $63.01 | $932K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 309 | $68.00 | $21K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 1K | $64.49 | $77K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 437 | $65.97 | $29K |
| Jan 5, 2026 | Hamilton James C | Chief Medical Officer | Sell(S) | 13K | $63.95 | $813K |
| Jan 2, 2026 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 6K | $66.39 | $383K |
| Jan 2, 2026 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 7K | $65.88 | $489K |
| Dec 31, 2025 | O'Brien Patrick | COO | Gift(G) | 560 | — | $0 |
| Dec 31, 2025 | O'Brien Patrick | COO | Gift(G) | 560 | — | $0 |
| Dec 31, 2025 | O'Brien Patrick | COO | Gift(G) | 560 | — | $0 |
| Dec 31, 2025 | O'Brien Patrick | COO | Gift(G) | 560 | — | $0 |
| Dec 31, 2025 | O'Brien Patrick | COO | Gift(G) | 560 | — | $0 |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 17K | $68.69 | $1.1M |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 35K | $69.33 | $2.4M |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Option exercise(M) | 17K | $6.15 | $102K |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Option exercise(M) | 35K | $6.15 | $216K |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Option exercise(M) | 17K | — | $0 |
| Dec 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Option exercise(M) | 35K | — | $0 |
| Dec 26, 2025 | Ferrari Mauro | Director | Sell(S) | 8K | $70.00 | $527K |
| Dec 22, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 3K | $68.85 | $177K |
| Dec 22, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 10K | $68.33 | $684K |
| Dec 19, 2025 | Olukotun Adeoye Y | Director | Sell(S) | 3K | $66.70 | $206K |
| Dec 19, 2025 | Olukotun Adeoye Y | Director | Sell(S) | 6K | $68.04 | $414K |
| Dec 19, 2025 | Olukotun Adeoye Y | Director | Sell(S) | 827 | $68.48 | $57K |
| Dec 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 4K | $66.67 | $265K |
| Dec 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 8K | $68.01 | $554K |
| Dec 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 1K | $68.48 | $90K |
| Dec 19, 2025 | Waddill William D. | Director | Sell(S) | 5K | $68.01 | $371K |
| Dec 19, 2025 | Waddill William D. | Director | Sell(S) | 2K | $66.66 | $161K |
| Dec 19, 2025 | Waddill William D. | Director | Sell(S) | 500 | $68.53 | $34K |
| Dec 19, 2025 | Vakiener Victoria | Director | Sell(S) | 3K | $66.63 | $186K |
| Dec 19, 2025 | Vakiener Victoria | Director | Sell(S) | 2K | $68.39 | $134K |
| Dec 19, 2025 | Vakiener Victoria | Director | Sell(S) | 5K | $67.97 | $359K |
| Dec 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 36K | $64.51 | $2.3M |
| Dec 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 982 | $65.53 | $64K |
| Dec 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 2K | $66.30 | $131K |
| Dec 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 46K | $63.55 | $2.9M |
| Dec 16, 2025 | Ingram Douglas S | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Olukotun Adeoye Y | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Perry Michael S | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 3K | $67.87 | $219K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 166 | $66.77 | $11K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 1K | $65.77 | $86K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 1K | $64.96 | $65K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 8K | $62.94 | $533K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 14K | $62.12 | $876K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 11K | $61.25 | $671K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 8K | $60.51 | $509K |
| Dec 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 7K | $64.29 | $428K |
| Dec 16, 2025 | Ferrari Mauro | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Waddill William D. | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Lu Hongbo | Director | Grant(A) | 8K | — | $0 |
| Dec 16, 2025 | Vakiener Victoria | Director | Grant(A) | 8K | — | $0 |
| Dec 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 8K | $69.96 | $570K |
| Dec 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 21K | $69.28 | $1.5M |
| Dec 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 101K | $68.67 | $6.9M |
| Dec 12, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Grant(A) | 180K | — | $0 |
| Dec 5, 2025 | Perry Michael S | Director | Sell(S) | 16K | $61.03 | $992K |
| Nov 28, 2025 | Ferrari Mauro | Director | Sell(S) | 9K | $56.39 | $493K |
| Oct 1, 2025 | Hamilton James C | Chief Medical Officer | Sell(S) | 20K | $35.00 | $700K |
| Sep 12, 2025 | Hamilton James C | Chief Medical Officer | Sell(S) | 15K | $30.00 | $450K |
| Sep 2, 2025 | Hamilton James C | Chief Medical Officer | Sell(S) | 15K | $25.00 | $375K |
| Aug 15, 2025 | Hamilton James C | Chief Medical Officer | Sell(S) | 9K | $20.00 | $188K |
| Aug 13, 2025 | Hamilton James C | Chief Medical Officer | Sell(S) | 611 | $20.00 | $12K |
| Apr 11, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 51K | $11.49 | $584K |
| Apr 10, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 50K | $10.87 | $544K |
| Apr 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 2K | $11.76 | $19K |
| Apr 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 3K | $10.75 | $37K |
| Apr 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 35K | $9.93 | $351K |
| Mar 13, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Sell(S) | 51K | $15.07 | $775K |
| Mar 13, 2025 | Anzalone Christopher Richard | Chief Executive Officer, Director | Grant(A) | 340K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).